Paricalcitol Market is estimated to grow at a significant CAGR during the forecast period. Paricalcitol is a synthesised (man-made) version of vitamin D. Calcium absorption from the stomach and calcium function in the body both require vitamin D. Paricalcitol is used to treat and prevent hyperparathyroidism in dialysis patients with chronic renal disease. Hyperparathyroidism is a condition in which the parathyroid glands in the neck overproduce parathyroid hormone (PTH).
This hormone regulates the calcium and phosphorus levels in your blood. Paricalcitol aids in the reduction of PTH, which reduces calcium and phosphorus levels. For the treatment of post-transplantation osteoporosis or in patients with chronic kidney diseases as well as vitamin D deficiency, Paricalcitol is used. Factors such as the rising incidence of chronic renal disease and the rising number of patients with secondary hyperparathyroidism might be attributed to the market’s expansion.
The Paricalcitol medication has been approved by the FDA for use in adults with stage 3 or 4 chronic renal disease who are on dialysis or have a creatinine clearance of less than 30 mL/min, as well as people with secondary hyperparathyroidism who are on dialysis (high levels of parathyroid hormone). Paricalcitol can be given intravenously or orally, depending on the patient’s condition and preference; it can also be given as a monthly injection under the skin (subcutaneously).
To Request a Sample of our Report on Paricalcitol Market: https://www.omrglobal.com/request-sample/paricalcitol-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2022-2030
Segments Covered
- By Type
- By Application
Regions Covered
- North America
- Europe
- Asia-Pacific
- Rest of the world
- Competitive Landscape: ChemWerth Inc, ALP Pharm Beijing Co., Ltd, Chongqing Huapont Pharmaceutical Co. Ltd, DISHMAN NETHERLANDS B.V., Haoyuan Chemexpress Co.Ltd.
A full Report of Paricalcitol Market is Available at: https://www.omrglobal.com/industry-reports/paricalcitol-market
Paricalcitol Market by Segments,
By Type:
- High Purity
- Low Purity
By Application:
- Injection Product
- Capsule Product
Paricalcitol Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/paricalcitol-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404